基于HIF-1α/Notch信号通路探讨加味济生肾气汤改善缺氧微环境抗肝硬化的机制研究
作者单位:

1.广西中医药大学;2.广西中医药大学第一附属医院;3.柳州市中医医院

基金项目:

国家自然科学基金(编号:81760855);广西中医药大学研究生教育创新计划项目(编号:YCSW2024404);广西中医药大学研究生教育创新计划项目(编号:YCBZ2024145) ;2023年中央引导地方科技发展资金项目(自由探索类基础研究类)(编号:2023YRZ0102)


Exploring the Mechanism of Modified Jisheng Shenqi Decoction in Improving Hypoxia Microenvironment and Preventing Cirrhosis Based on HIF-1 α/Notch Signaling Pathway
Author:
Affiliation:

1.Guangxi University of Chinese Medicine;2.The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine;3.Liuzhou Traditional Chinese Medical Hospital

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    目的 探究加味济生肾气汤改善缺氧微环境拮抗肝硬化的机制。方法 体内实验用四氯化碳诱导制备大鼠肝硬化模型,设置正常组、模型组、秋水仙碱组和加味济生肾气汤低、中、高剂量组。HE染色和 Masson 染色观察各组大鼠肝组织病理改变;试剂盒检测各组大鼠血清肝功能变化;Elisa检测各组大鼠透明质酸(Hyaluronic Acid,HA)、层粘连蛋白(Laminin,LN)、Ⅲ型前胶原(Procollagen III,PCIII)、Ⅳ型胶原(Collagen Type IV,COL4)水平; Western blot 检测大鼠缺氧诱导因子-1α(hypoxia inducible factor-1α)、Notch1、Jagged1、α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)蛋白表达。体外实验以 HSC-T6 细胞为研究对象,CCK-8 法筛选出CoCl2培养细胞最适宜(100 μM、200 μM、400 μM、600 μM、800 μM)浓度及含药血清(5%、10%、15%、20%)最佳干预浓度;划痕试验检测各组细胞迁移能力;流式细胞术检测各组细胞凋亡率变化;Western Blot检测各组细胞内HIF-1α、Notch1、Jagged1、a-SMA、基质金属蛋白酶9(MMP9)、基质金属蛋白酶抑制剂-1(TIMP-1)蛋白表达情况。结果 体内实验:与对照组比较,模型组大鼠肝脏肿胀、炎性细胞浸润和胶原沉积明显增多,假小叶出现,血清ALT、AST、HA、LN、PCIII、COL4 水平明显增高,ALB显著降低,肝组织HIF-1α、Notch1、Jagged1、α-SMA蛋白表达明显升高(P < 0.01),与模型组比较,各治疗组大鼠肝脏肿胀、炎性细胞浸润和胶原沉积明显减少,纤维化程度减轻,血清ALT、AST、HA、LN、PCIII、COL4 水平明显降低,ALB显著增高,肝组织HIF-1α、Notch1、Jagged1、α-SMA蛋白表达均有不同程度降低(P < 0.05);体外实验:缺氧能够促进HSC-T6迁移,减少HSC-T6凋亡,并提高HIF-1α、Notch1、Jagged1、a-SMA、TIMP-1蛋白表达,降低MMP9蛋白表达(P < 0.01),加味济生肾气汤含药血清能够抑制HSC-T6迁移,促进HSC-T6凋亡,并降低HIF-1α、Notch1、Jagged1、a-SMA、TIMP-1蛋白表达,升高MMP9蛋白表达(P < 0.01),但其对 HSC-T6 细胞活化抑制的作用可被HIF-1α激动剂DMOG 逆转。结论 加味济生肾气汤能够通过HIF-1α/Notch通路改善缺氧微环境,进而发挥抗肝硬化的作用。

    Abstract:

    Objective: To explore the mechanism of Jiawei Jisheng Shenqi Decoction in improving the hypoxic microenvironment and antagonizing liver cirrhosis. Method: In vivo experiments were conducted on a rat model of liver cirrhosis induced by carbon tetrachloride. Normal group, model group, colchicine group, and low, medium, and high dose groups of Jiawei Jisheng Shenqi Decoction were set up. HE staining and Masson staining were used to observe the pathological changes in liver tissue of rats in each group;Test kit was used to to detect changes in serum liver function in each group of rats; Elisa was used to detect the levels of hyaluronic acid (HA), laminin (LN), procollagen III (PCIII)and collagen type IV(COL4) in each group of rats; Western blot was used to detect the expression of hypoxia inducible factor-1α(HIF-1α), Notch1, Jagged1, and α-smooth muscle actin(α-SMA) proteins in rats. In vitro experiments were conducted on HSC-T6 cells, and the CCK-8 method was used to screen for the most suitable (100 μM, 200 μM, 400 μM, 600 μM, 800 μM) concentrations of CoCl2 cultured cells and the optimal intervention concentrations of drug containing serum (5%, 10%, 15%, 20%); Scratch test was used to detect the migration ability of cells in each group; Flow cytometry was used to detect changes in apoptosis rate of cells in each group; Western blot was used to detect the expression of HIF-1α, Notch1, Jagged1, a-SMA, Matrix Metallopeptidase 9(MMP9), and Tissue Inhibitor of Metalloproteinases 1(TIMP-1) proteins in each group of cells. Results:In vivo experiment: Compared with the control group, the model group rats showed significantly increased liver swelling, inflammatory cell infiltration, and collagen deposition, as well as the appearance of pseudolobules. The levels of serum ALT, AST, HA, LN, PCIII, COL4 were significantly increased, while ALB was significantly decreased. The expression of HIF-1α, Notch1, Jagged1, and α-SMA proteins in liver tissue was significantly increased (P<0.01). Compared with the model group, the liver swelling, inflammatory cell infiltration, and collagen deposition in each treatment group rats were significantly reduced, and the degree of fibrosis was reduced. The levels of serum ALT, AST, HA, LN, PCIII, COL4 were significantly decreased, while ALB was significantly increased. The expression of HIF-1α, Notch1, Jagged1, and α-SMA proteins in liver tissue was also significantly increased. Decreased to varying degrees (P<0.05). In vitro experiments: Hypoxia can promote HSC-T6 migration, reduce HSC-T6 apoptosis, and increase the expression of HIF-1α, Notch1, Jagged1, a-SMA, and TIMP-1 proteins, while reducing the expression of MMP9 protein (P<0.01). The serum containing Jiawei Jisheng Shenqi Decoction can inhibit HSC-T6 migration, promote HSC-T6 apoptosis, and lower the expression of HIF-1α, Notch1, Jagged1, a-SMA, and TIMP-1 proteins, while enhance the expression of MMP9 protein (P<0.01). However, its inhibitory effect on HSC-T6 cell activation can be reversed by the HIF-1 α agonist DMOG. Conclusion: Jiawei Jisheng Shenqi Decoction can improve the hypoxic microenvironment through the HIF-1α/Notch pathway, thereby exerting an anti liver cirrhosis effect.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-11-18
  • 最后修改日期:2025-02-03
  • 录用日期:2025-02-18
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭